ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,153Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 1125

$1.28M Total Retail Price of All Prescriptions

Rank: 54 out of 1125

734 Patients Receiving at Least One Drug in Part D
71% Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kentucky
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 734 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 734 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 995 521 137 S3 1 1
LEVOTHYROXINE SODIUM 948 708 133 2 3
OMEPRAZOLE 839 532 136 3 4
AMLODIPINE BESYLATE 741 576 110 4 6
SIMVASTATIN 633 525 94 5 5
LISINOPRIL 626 478 108 6 2
FUROSEMIDE 607 519 114 7 7
METFORMIN HCL 573 359 98 8 8
ALPRAZOLAM 552 328 70 B 9 16
ATORVASTATIN CALCIUM 487 367 82 10 9
CITALOPRAM HBR 450 317 73 11 19
CLONAZEPAM 434 269 66 B 12 32
METOPROLOL TARTRATE 426 373 63 13 11
POTASSIUM CHLORIDE 403 349 68 14 14
CLOPIDOGREL 396 286 63 15 15
GABAPENTIN 383 181 55 16 10
PRAVASTATIN SODIUM 369 264 67 17 13
LORAZEPAM 270 212 45 B 18 30
MELOXICAM 268 143 68 19 25
LOSARTAN POTASSIUM 234 160 38 20 23
METOPROLOL SUCCINATE 230 180 36 21 17
WARFARIN SODIUM 214 184 27 22 18
HYDROCHLOROTHIAZIDE 214 181 39 22 12
NAMENDA 214 202 22 22 38
BISOPROLOL-HYDROCHLOROTHIAZIDE 213 161 31 25 158
JANUVIA 213 160 28 25 53
SERTRALINE HCL 212 98 29 27 22
CRESTOR 195 114 35 28 29
CARVEDILOL 194 155 29 29 26
ZOLPIDEM TARTRATE 192 113 30 30 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 105 29 31 28
RANITIDINE HCL 184 132 30 32 24
CYMBALTA 179 94 23 33 45
TAMSULOSIN HCL 176 139 34 34 34
NEXIUM 173 84 26 35 20
TRIAMTERENE-HCTZ 171 150 24 36 69
GLIMEPIRIDE 165 97 24 37 46
ZETIA 162 134 23 38 77
GEMFIBROZIL 162 132 26 38 113
LOSARTAN-HYDROCHLOROTHIAZIDE 161 123 27 40 56
TRAMADOL HCL 160 76 36 41 31
ATENOLOL 157 85 22 42 21
DONEPEZIL HCL 150 138 17 43 42
TIZANIDINE HCL 150 95 50 43 74
SYNTHROID 142 126 29 45 71
DIAZEPAM 139 87 26 B 46 37
DIOVAN 138 111 17 47 57
FENOFIBRATE* 138 71 18 47 55
METHOCARBAMOL 137 29 30 R 49 164
CIPROFLOXACIN HCL 134 99 65 50 68
SULFAMETHOXAZOLE-TRIMETHOPRIM 122 87 78 51 89
AZITHROMYCIN 122 76 101 51 47
ALLOPURINOL 120 101 19 53 40
VENLAFAXINE HCL ER 118 64 14 54 103
POLYETHYLENE GLYCOL 3350 116 95 32 55 54
FLUTICASONE PROPIONATE 115 80 35 56 41
TRAZODONE HCL 115 71 16 56 36
DOXAZOSIN MESYLATE 112 107* 14 58 91
FLUOXETINE HCL 110 41 21 59 48
ISOSORBIDE MONONITRATE ER 110 105* 22 59 43
OXYCODONE-ACETAMINOPHEN 109 72 26 S2 61 105
AMITRIPTYLINE HCL 108 66 17 R 62 51
VERAPAMIL ER 106 69 16 63 122
FENOFIBRATE* 103 85 14 64 55
LANSOPRAZOLE 100 66 19 65 106
PROAIR HFA 99 50 29 66 39
AMOXICILLIN 98 64 70 67 84
SPIRIVA 95 54 18 68 60
ESCITALOPRAM OXALATE 95 73 13 68 52
CYCLOBENZAPRINE HCL 94 14 15 R 70 73
MONTELUKAST SODIUM 94 76 18 70 35
QUETIAPINE FUMARATE 93 69 17 A 72 76
DILTIAZEM 24HR ER 91 75 16 73 153
LYRICA 89 20 14 74 82
TOVIAZ 81 <11 <11 75 286
BYSTOLIC 80 62 13 76 118
CARISOPRODOL 79 23 18 R 77 175
FAMOTIDINE* 78 73* 12 78 109
SOTALOL 77 66 11 79 238
TRIAMCINOLONE ACETONIDE 76 55 28 80 130
PROMETHAZINE HCL 74 49 24 R 81 72
PREDNISONE 73 50 28 82 44
LEVOFLOXACIN 71 49 40 83 67
ALENDRONATE SODIUM 68 56 11 84 50
MORPHINE SULFATE ER 68 26 12 S2 84 155
PIOGLITAZONE HCL 68 <11 <11 R 84 95
VYTORIN 67 51 12 87 190
ADVAIR DISKUS 67 25 14 87 61
PHENYTOIN SODIUM EXTENDED 65 <11 <11 89 149
BENAZEPRIL HCL 63 37 12 90 88
AMLODIPINE BESYLATE-BENAZEPRIL 63 58* 12 90 85
BUMETANIDE 63 51 13 90 121
VALSARTAN-HYDROCHLOROTHIAZIDE 62 <11 <11 93 102
QUINAPRIL HCL 61 <11 <11 94 140
HYDROXYZINE HCL 61 42 11 R 94 188
PANTOPRAZOLE SODIUM 61 56* 12 94 27
OXYCODONE HCL-ACETAMINOPHEN 59 12 11 S2 97 70
NIASPAN 58 <11 <11 98 145
OXYBUTYNIN CHLORIDE 57 <11 <11 99 150
THEOPHYLLINE ANHYDROUS 56 <11 <11 100 166
ABILIFY 55 <11 <11 A 101 129
PAROXETINE HCL 55 43 11 101 49
NIFEDIPINE ER 54 <11 <11 103 142
IBUPROFEN 54 49* 12 103 65
KLOR-CON M20 53 53 11 105 79
CLONIDINE HCL 52 47* 16 106 58
FLUCONAZOLE 51 16 29 107 137
AVODART 51 <11 <11 107 186
BUPROPION HCL SR 51 36 12 107 192
KLOR-CON 10 51 <11 <11 107 125
GLIPIZIDE XL 50 <11 <11 111 147
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.